Results 61 to 70 of about 1,426 (171)
Objective To evaluate the efficacy of combined therapy of compound betamethasone periocular injection and oral mycophenolate mofetil (MMF) in treating active thyroid‐associated ophthalmopathy (TAO). Methods A retrospective study was conducted on 17 patients with active TAO treated with compound betamethasone periocular injection combined with oral MMF ...
Chunchun Xiao +6 more
wiley +1 more source
While orbital decompression is recommended for severe, refractory thyroid eye disease according to the ATA‐ETA Consensus Statement in 2022, there are no clear guidelines regarding the optimal surgical approach. We conducted a survey completed by otolaryngologists that assessed pre‐operative, operative, and post‐operative management preferences for ...
Ryan C. Higgins +2 more
wiley +1 more source
Ocular immune‐related diseases: molecular mechanisms and therapy
The molecular mechanisms underlying ocular immune‐related diseases is due to the dysregulation of immune responses. The unbalanced activation of diverse immune cell types, inflammatory activators and pathways are related to the immunological pathogenesis of ocular immune‐related disease which paly an essential role of immune processes in the ...
Yakun Wang +5 more
wiley +1 more source
Precise cellular targeting will expand the potential of CRISPR‐Cas‐mediated gene editing. For linking the large Cas9 enzyme to IgG antibodies as prime targeting devices, protein trans‐splicing under non‐reducing conditions is shown to efficiently form the desired conjugate from the separately produced and purified entities, providing the first step of ...
Tim Pasch +4 more
wiley +1 more source
Rapid response of thyroid eye disease, peripheral edema, and acropathy to teprotumumab infusion
Purpose: We present a case of rapid improvement in symptoms of thyroid eye disease and amelioration of worsening peripheral edema and acropathy with infusion of teprotumumab, a monoclonal antibody targeting the insulin-like growth factor-1 receptor ...
David A. Kelly, Roger E. Turbin
doaj +1 more source
The circulating IL‐35+ regulatory B cells are associated with thyroid associated opthalmopathy
The percentage of circulating IL‐35+Bregs was elevated in thyroid‐associated ophthalmopathy (TAO), and the increase was positively correlated with disease activity. IL‐35 significantly prompted the induction of IL‐35+Bregs in healthy controls, but the B cells in TAO showed potential impairment in the transition of B cells towards IL‐35+Breg phenotype ...
Qian Li +8 more
wiley +1 more source
Better therapies for childhood cancer remain an unmet need to improve the dismal prognosis of certain malignancies and to reduce the burden of toxicity. Rescuing discontinued or shelved drugs for children, adolescents, and young adults is a strategy to identify new uses for approved or investigational medicines outside the scope of their original ...
Teresa de Rojas +6 more
wiley +1 more source
Comparative Efficacy of Medical Treatments for Thyroid Eye Disease: A Network Meta-Analysis
Purpose. Numerous medical strategies have been proposed for the treatment of thyroid eye disease (TED); however, the best methods for standard treatment are still a matter of controversy.
Nuo Xu, Yi Cui, Tianlu Xie, Mi Zheng
doaj +1 more source
Outcomes of Strabismus Surgery Following Teprotumumab Therapy
PURPOSE: To investigate the results of patients undergoing surgical treatment for strabismic diplopia in thyroid eye disease (TED) following teprotumumab. DESIGN: Multicenter, retrospective, case series.
Peragallo, Jason H +10 more
core +1 more source
Research report supplemental figure.Context: Teprotumumab, an IGF-I receptor inhibitor (IGF-IR), is effective in thyroid-associated ophthalmopathy (TAO).
Smith, Terry
core +1 more source

